Zenopharm
Dr. Miele is experienced in translational research and investigator initiated proof-of-principle clinical trials, with a focus on the treatment of breast cancer. Dr. Miele serves as clinical consultant for Zenopharm.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Zenopharm
Zenopharm is a startup pharmaceutical company founded in 2012 to commercialize innovative oncology therapeutics based on its patented platform technology. Zenopharm is developing transformational therapeutic solutions for the treatment of advanced or metastatic breast cancer.